Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Mar 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5025513017 | Product containing only dicycloverine and mefenamic acid in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5025514011 | Dicycloverine and mefenamic acid only product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 5025521011 | Dicyclomine and mefenamic acid only product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only dicycloverine and mefenamic acid in oral dose form (medicinal product form) | Is a | Product containing only dicycloverine and mefenamic acid (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only dicycloverine and mefenamic acid in oral dose form (medicinal product form) | Is a | Product containing dicycloverine and mefenamic acid in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only dicycloverine and mefenamic acid in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only dicycloverine and mefenamic acid in oral dose form (medicinal product form) | Has active ingredient | Dicycloverine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only dicycloverine and mefenamic acid in oral dose form (medicinal product form) | Has active ingredient | Mefenamic acid | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only dicycloverine and mefenamic acid in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR